[1] Vikas Pathak,Iliana Samara Hurtado Rendon,Irida Hasalla,et al.Evaluation of solitary pulmonary nodule in human immunodeficiency virus infected patients[J]. Respir Care, 2012, 57(7): 1115-1120. [2] Jasmer RM, Edinburgh KJ, Thompson A, et al.Clinical and radiographic predictors of theetiology of pulmonary nodules in HIV-infected patients[J]. Chest, 2000, 117(4):1023-1030. [3] Shiels MS, Pfeiffer RM, Gail MH, et al.Cancer burden in the HIV-infected population in the United States[J]. JNCI, 2011, 103:753-762. [4] Winstone TA, Man SF, Hull M, et al.Epidemic of lung cancer in patients with HIV infection[J]. Chest, 2013, 143:305-314. [5] Keith Sigel, Alain Makinson, Jonathan Thaler, et al.Lung cancer in persons with HIV[J]. Curr Opin HIV AIDS, 2017, 12(1): 31-38. [6] Tirelli U, Spina M, Sandri S,et al.Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors[J]. Cancer, 2000, 88(3): 563-569. [7] Bower M, Powles T, Nelson M,et al.HIV-related lung cancer in the era of highly active antiretroviral therapy[J].Aids,2003, 17(3): 371-375. [8] Gregory D Kirk, Christian Merlo, Peter O’Driscoll, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking[J]. Clin Infect Dis, 2007, 45(1): 103-110. [9] Sigel K, Crothers, K,Gordon K, et al. CD4 Measures as Predictors of Lung Cancer Risk and Prognosis in HIV Infection[R]. Conference on Retroviruses and Opportunistic Infections, 2015; Seattle, WA. 2015. [10] Shebl FM, Engels EA, Goedert JJ, et al.Pulmonary infections and risk of lung cancer among persons with AIDS[J]. J Acquir Immune Defic Syndr, 2010, 55: 375-379. [11] Almodovar S.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS[J]. Viral Immunol,2014, 27:186-199. [12] Sigel K, Wisnivesky J, Gordon K, et al.HIV as an independent risk factor for incident lung cancer[J]. AIDS, 2012, 26: 1017-1025. [13] Shiels MS, Cole SR, Mehta SH, et al.Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users[J]. J Acquir Immune Defic Syndr, 2010, 55: 510-515. [14] Alicia Hulbert, Craig M. Hooker, Jeanne C, et al.Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers[J]. J Thorac Oncol, 2014, 9(6): 752-759. [15] Ford N, Shubber Z, Meintjes G, et al.Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis[J]. Lancet HIV, 2015, 2(10): e438-444. [16] Swapndeep Singh atwal, Swapnil puraniK, ramavathu Kumar venu madhav, et al.High Resolution Computed Tomography Lung Spectrum in Symptomatic Adult HIV-Positive Patients in South-East Asian Nation[J]. J Clin Diagn Res, 2014, 8(6): Rc12-16. [17] Vittor AY, Garland JM, Gilman RH.Molecular diagnosis of TB in the HIV positive population[J]. Ann Global Health, 2014, 80: 476-485. [18] Steingart KR, Ng V, Henry M,et al.Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review[J]. Lancet Infect Dis, 2006, 6: 664-674. [19] Gray CM, Katamba A, Narang P, et al.Feasibility and operational performance of tuberculosis detection by loop-mediated isothermal amplification platform in decentralized settings: results from a multicenter study[J]. J Clin Microbiol, 2016, 54:1984-1991. [20] World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampin Resistance: Xpert MTB/RIF System for the Diagnosis of pulmonary and extra-pulmonary TB in Adults and Children[EB/OL]. Policy update. Geneva, Switzerland:WHO,2013.http://www.stoptb.org/wg/gli/assets/documents/WHO%20Policy%20Statement%20on %20Xpert%20MTB-RIF%202013%20pre%20publication%20221 02013.pdf. Accessed 3 August 2016. [21] Sakamuri RM, Price DN, Lee M, et al.Association of lipoarabinomannan with high density lipoprotein in blood: implications for diagnostics[J]. Tuberculosis, 2013, 93: 301-307. [22] Lawn SD.Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review[J]. BMC Infect Dis,2012,12:103. [23] Sharma SK,Mohan A,Kadhiravan T.HIV -TB co -infection:epidemiology,diagnosis and management[J]. Indian J Med Res, 2005, 121(4):550-567. |